Drug Shortage Report for BRIVLERA

Last updated on 2020-06-10 History
Report ID 116350
Drug Identification Number 02452944
Brand name BRIVLERA
Common or Proper name BRIVARACETAM
Company Name UCB CANADA INC
Market Status MARKETED
Active Ingredient(s) BRIVARACETAM
Strength(s) 25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 60 TABS
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-06-02
Actual start date 2020-06-01
Estimated end date 2020-06-08
Actual end date 2020-06-08
Shortage status Resolved
Updated date 2020-06-10
Company comments
Health Canada comments
Contact Address 2201 BRISTOL CIRCLE
OAKVILLE, ONTARIO
CANADA L6H 0J8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-06-10 French Compare
v3 2020-06-10 English Compare
v2 2020-06-02 French Compare
v1 2020-06-02 English Compare